Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Journal of Molecular Endocrinology|May 1, 2014
PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cellsMomoe Itsumi, Masaki Shiota, Akira Yokomizo, et al.
The Journal of Urology|August 11, 2016
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase InhibitorMasaki Shiota, Keijiro Kiyoshima, Akira Yokomizo, et al.
Frontiers in Oncology|January 9, 2019
Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation TherapyMasaki Shiota, Naohiro Fujimoto, Kenjiro Imada, et al.
Clinical Genitourinary Cancer|May 1, 2019
Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese MenMasaki Shiota, Naohiro Fujimoto, Shigehiro Tsukahara, et al.
Annals of Surgical Oncology|November 30, 2016
The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate CancerMasaki Shiota, Ario Takeuchi, Masaaki Sugimoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2013
Inhibition of protein kinase C/Twist1 signaling augments anticancer effects of androgen deprivation and enzalutamide in prostate cancerMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.
Cancer Immunology, Immunotherapy : CII|October 12, 2012
YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-αArio Takeuchi, Masaki Shiota, Katsunori Tatsugami, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 1, 2022
Validation of models predicting lymph node involvement probability in patients with prostate cancerLeandro Blas, Masaki Shiota, Shohei Nagakawa, et al.
International Cancer Conference Journal|June 1, 2019
Progression to bone-marrow carcinomatosis and extraosseous legion during treatment with radium-223 for multiple bone metastasesTakahiko Hajime, Masaki Shiota, Tatsuro Abe, et al.
The Prostate|April 15, 2014
Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancerMasaki Shiota, Momoe Itsumi, Akira Yokomizo, et al.
Pageof 12